Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Adeberg, Sebastian [VerfasserIn]   i
 Harrabi, Semi B. [VerfasserIn]   i
 Bougatf, Nina [VerfasserIn]   i
 Windisch, Paul [VerfasserIn]   i
 Bernhardt, Denise [VerfasserIn]   i
 Combs, Stephanie [VerfasserIn]   i
 Herfarth, Klaus [VerfasserIn]   i
 Debus, Jürgen [VerfasserIn]   i
 Rieken, Stefan [VerfasserIn]   i
Titel:Dosimetric comparison of proton radiation therapy, volumetric modulated arc therapy, and three-dimensional conformal radiotherapy based on intracranial tumor location
Verf.angabe:Sebastian Adeberg, Semi B. Harrabi, Nina Bougatf, Vivek Verma, Paul Windisch, Denise Bernhardt, Stephanie E. Combs, Klaus Herfarth, Juergen Debus and Stefan Rieken
E-Jahr:2018
Jahr:26 October 2018
Umfang:15 S.
Fussnoten:Gesehen am 22.11.2018
Titel Quelle:Enthalten in: Cancers
Ort Quelle:Basel : MDPI, 2009
Jahr Quelle:2018
Band/Heft Quelle:10(2018), 11, Artikel-ID 401
ISSN Quelle:2072-6694
Abstract:(1) Background: Selecting patients that will benefit the most from proton radiotherapy (PRT) is of major importance. This study sought to assess dose reductions to numerous organs-at-risk (OARs) with PRT, as compared to three-dimensional conformal radiotherapy (3DCRT) and volumetric-modulated arc therapy (VMAT), as a function of tumor location. (2) Materials/Methods: Patients with intracranial neoplasms (all treated with PRT) were stratified into five location-based groups (frontal, suprasellar, temporal, parietal, posterior cranial fossa; n = 10 per group). Each patient was re-planned for 3DCRT and intensity-modulated radiotherapy (IMRT) using similar methodology, including the originally planned target and organ-at-risk (OAR) dose constraints. (3) Results: In parietal tumors, PRT showed the most pronounced dose reductions. PRT lowered doses to nearly every OAR, most notably the optical system and several contralateral structures (subventricular zone, thalamus, hippocampus). For frontal lobe cases, the greatest relative dose reductions in mean dose (Dmean) with PRT were to the infratentorial normal brain, contralateral hippocampus, brainstem, pituitary gland and contralateral optic nerve. For suprasellar lesions, PRT afforded the greatest relative Dmean reductions to the infratentorial brain, supratentorial brain, and the whole brain. Similar results could be observed in temporal and posterior cranial fossa disease. (4) Conclusions: The effectiveness and degree of PRT dose-sparing to various OARs depends on intracranial tumor location. These data will help to refine selection of patients receiving PRT, cost-effectiveness, and future clinical toxicity assessment.
DOI:doi:10.3390/cancers10110401
URL:kostenfrei: Volltext: http://dx.doi.org/10.3390/cancers10110401
 kostenfrei: Volltext: https://www.mdpi.com/2072-6694/10/11/401
 DOI: https://doi.org/10.3390/cancers10110401
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:3D conformal radiotherapy
 astrocytoma
 cost-effectiveness
 craniopharyngioma
 glioblastoma
 glioma
 IMPT
 IMRT
 neurocognition
 proton therapy
 VMAT
K10plus-PPN:1583973494
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68331183   QR-Code
zum Seitenanfang